SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012114
Filing Date
2019-08-13
Accepted
2019-08-13 06:31:38
Documents
63
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 795355
2 ex31-1.htm EX-31.1 11284
3 ex31-2.htm EX-31.2 11286
4 ex32-1.htm EX-32.1 7917
5 image_001.jpg GRAPHIC 7016
  Complete submission text file 0001493152-19-012114.txt   3820963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtnb-20190630.xml EX-101.INS 536163
7 XBRL SCHEMA FILE mtnb-20190630.xsd EX-101.SCH 49017
8 XBRL CALCULATION FILE mtnb-20190630_cal.xml EX-101.CAL 58174
9 XBRL DEFINITION FILE mtnb-20190630_def.xml EX-101.DEF 207834
10 XBRL LABEL FILE mtnb-20190630_lab.xml EX-101.LAB 351924
11 XBRL PRESENTATION FILE mtnb-20190630_pre.xml EX-101.PRE 272989
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 191018185
SIC: 2834 Pharmaceutical Preparations